| abstract |
The present invention includes tauopathy, synucleinopathy, polyglutamine disease and polyalanine disease, leukodystrophy, cystic fibrosis, multiple sclerosis, lysosomal storage disorder, amyloidosis disease, inflammation, metabolic disorder, cardiovascular disorder, osteoporosis, A compound of formula (I) or a tautomer in the treatment of a disorder associated with the PPP1R15A pathway and associated with protein misfolding stress, particularly misfolded protein, selected in the group of nervous system trauma, ischemia / Or a pharmaceutically acceptable salt thereof Related to new uses. |